Drug candidate | Human intestinal absorption (+ve/−ve) | Blood–brain barrier (+ve/−ve) | Human oral bioavailability (+ve/−ve) | Water solubility logS | Acute oral toxicity (kg/mol) | Tetrahymenapyriformisp IGC50 (ug/L) |
---|---|---|---|---|---|---|
DHB 1 | HIA+ | BBB+ | HOB − | −4.249 | 2.885 | 2.08 |
DHB 2 | HIA + | BBB + | HOB − | −3.095 | 2.773 | 1.584 |
DHB 3 | HIA + | BBB + | HOB − | −3.095 | 2.694 | 2.032 |
DHB 4 | HIA + | BBB + | HOB + | −2.871 | 1.685 | 1.267 |
DHB 5 | HIA + | BBB + | HOB − | −2.605 | 1.514 | 1.223 |
DHB 6 | HIA + | BBB + | HOB − | −2.733 | 2.227 | 1.291 |
DHB 7 | HIA + | BBB + | HOB − | −2.851 | 2.15 | 1.256 |
DHB 8 | HIA + | BBB + | HOB − | −2.536 | 3.041 | 0.949 |
DHB 9 | HIA + | BBB + | HOB + | −2.546 | 2.672 | 0.996 |
DHB 10 | HIA + | BBB + | HOB − | −2.977 | 2.36 | 1.543 |
DHB 11 | HIA + | BBB + | HOB + | −3.196 | 2.43 | 1.4 |
DHB 12 | HIA + | BBB + | HOB − | −2.506 | 1.871 | 1.591 |